Browse

Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice

DC Field Value Language
dc.contributor.authorChoi, Se-Young-
dc.contributor.authorHayashi, Mansuo L-
dc.contributor.authorShankaranarayana Rao, B. S-
dc.contributor.authorSeo, Jin-Soo-
dc.contributor.authorChoi, Han-Saem-
dc.contributor.authorDolan, Bridget M-
dc.contributor.authorChattarji, Sumantra-
dc.contributor.authorTonegawa, Susumu-
dc.date.accessioned2010-07-23-
dc.date.available2010-07-23-
dc.date.issued2007-05-
dc.identifier.citationProceedings of the National Academy of Sciences of the United States of America 104:11489-11494.en
dc.identifier.issn0027-8424-
dc.identifier.urihttps://hdl.handle.net/10371/68655-
dc.description.abstractFragile X syndrome (FXS), the most commonly inherited form of mental retardation and autism, is caused by transcriptional silencing of the fragile X mental retardation 1 (FMR1) gene and consequent loss of the fragile X mental retardation protein. Despite growing evidence suggesting a role of specific receptors and biochemical pathways in FXS pathogenesis, an effective therapeutic method has not been developed. Here, we report that abnormalities in FMR1 knockout (KO) mice, an animal model of FXS, are ameliorated, at least partially, at both cellular and behavioral levels, by an inhibition of the catalytic activity of p21-activated kinase (PAK), a kinase known to play a critical role in actin polymerization and dendritic spine morphogenesis. Greater spine density and elongated spines in the cortex, morphological synaptic abnormalities commonly observed in FXS, are at least partially restored by postnatal expression of a dominant negative (dn) PAK transgene in the forebrain. Likewise, the deficit in cortical long-term potentiation observed in FMR1 KO mice is fully restored by the dnPAK transgene. Several behavioral abnormalities associated with FMR1 KO mice, including those in locomotor activity, stereotypy, anxiety, and trace fear conditioning are also ameliorated, partially or fully, by the dnPAK transgene. Finally, we demonstrate a direct interaction between PAK and fragile X mental retardation protein in vitro. Overall, our results demonstrate the genetic rescue of phenotypes in a FXS mouse model and suggest that the PAK signaling pathway, including the catalytic activity of PAK, is a novel intervention site for development of an FXS and autism therapy.en
dc.language.isoenen
dc.publisherNational Academy of Sciencesen
dc.titleInhibition of p21-activated kinase rescues symptoms of fragile X syndrome in miceen
dc.typeArticleen
dc.contributor.AlternativeAuthor최세영-
dc.contributor.AlternativeAuthor서진수-
dc.contributor.AlternativeAuthor최한샘-
dc.identifier.doi10.1073/pnas.0705003104-
Appears in Collections:
College of Dentistry/School of Dentistry (치과대학/치의학대학원)Dept. of Dentistry (치의학과)Journal Papers (저널논문_치의학과)
Files in This Item:
There are no files associated with this item.
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse